January 20, 1975

Immunosuppression: Systemic Lupus Erythematosus

Author Affiliations

Veterans Administration Hospital Pittsburgh


edited by J. Rotstein (Rheumatology: An Annual Review, vol 5), 274 pp, 19 illus, $42, S Karger (White Plains, NY, Albert J Phiebig), 1974.

JAMA. 1975;231(3):304. doi:10.1001/jama.1975.03240150058035

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


The authors of the first article state that they had two goals in preparing it: (1) to determine from published data whether treatment of various "immunoinflammatory" diseases with nonspecific immunosuppressant nonsteroidal drugs is justified, and (2) to stress the importance of conducting controlled evaluations of such drugs. They summarize numerous reports of therapeutic trials, most of which were uncontrolled, and group them according to the clinical diagnosis, in two tables. The toxic effects of these agents are briefly presented, but no space is given to their pharmacology or cellular effects. The authors conclude that treatment with immunosuppressive drugs "has a vast potential." Primarily, they make a plea that rigorous therapeutic trials be performed to establish the indications for specific agents in specific disease states. Much information is conveniently compressed within these 48 pages, which include a bibliography of 238 references. None are more recent than 1971, which, in a field